Table 2. General information and inter-group analysis of ALU-115 /ALU-219 /CA-125.
| 115(ng/μL) | M-W | P | 219(ng/μL) | M-W | P | CA-125 | M-W | P | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M(P25-P75) | 95% CI | Z | M(P25-P75) | 95% CI | Z | M(P25-P75) | 95%CI | Z | ||||
|
ovarian cancer
1 n = 24 |
19.44 (13.74–29.80) |
16.71- 37.01 |
1 vs. 2 -1.443 |
0.149 | 11.88 (6.46–16.31) |
7.27- 35.46 |
1 vs. 2 -2.215 |
0.027* | 474.35 (78.23–1627.75) |
12.21- 23.94 |
1 vs. 2 -4.027 |
<0.0001* |
|
benign cyst
2 n = 12 |
14.92 (8.33–24.41) |
8.81- 17.62 |
5.46 (3.71–8.24) |
3.39- 11.74 |
27.56 (17.65–57.21) |
4.93- 9.29 |
||||||
|
Norma3 N = 12 |
14.41 (13.33–19.27) |
490.29- 1783.90 |
2 vs. 3 -0.520 |
0.603 | 5.75 (4.56–9.71) |
19.28- 51.71 |
2 vs. 3 -0.462 |
0.644 | 18.38 (11.19–25.24) |
13.60- 23.90 |
2 vs. 3 -1.848 |
0.065 |
Kruskal-Wallis H analysis on ALU-115/ALU-219/CA-125 in the three groups was x2 = 2.932, p = 0.231; x2 = 7.516, p = 0.023*; x2 = 28.98, p = 0.000*, respectively.
*P<0.05, statistically significant.
M-W refers to Mann-Whitney U analysis.